FEASIBILITY AND EFFICACY OF DHAOX REGIMEN AS SALVAGE AND MOBILIZING THERAPY IN RELAPSED /REFRACTORY LYMPHOMAS

被引：0

作者：

Coviello, E. ^{[1
]}

Giannoni, L. ^{[1
]}

Pastori, G. ^{[1
]}

Mitscheunig, L. ^{[1
]}

Avenoso, D. ^{[1
]}

Minetto, P. ^{[1
]}

Guolo, F. ^{[1
]}

Miglino, M. ^{[1
]}

Clavio, M. ^{[1
]}

Lemoli, R. M. ^{[1
]}

Marco, G. ^{[1
]}

Ballerini, F. ^{[1
]}

机构：

[1] Univ Genoa, IRCCS AOU San Martino IST, Dept Internal Med DiMI, Chair Hematol, Genoa, Italy

来源：

HAEMATOLOGICA | 2016年 / 101卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

E972

引用

页码：399 / 400

页数：2

共 50 条

[41] THE MINE REGIMEN AS INTENSIVE SALVAGE CHEMOTHERAPY FOR RELAPSED AND REFRACTORY HODGKINS-DISEASE
FERME, C
BASTION, Y
LEPAGE, E
BERGER, F
BRICE, P
MOREL, P
GABARRE, J
NEDELLEC, G
REMAN, O
CHERON, N
OBERLIN, O
COIFFIER, B
ANNALS OF ONCOLOGY, 1995, 6 (06) : 543 - 549
[42] Latest results of GVM±R regimen for the salvage therapy of patients with relapsed or refractory aggressive nonHodgkin's lymphoma
Liu, W.
Huang, W.
Xu, Y.
Wang, T.
Yi, S.
Sui, W.
Wang, Y.
Wang, Q.
Yu, T.
Yan, Y.
Zhang, S.
Zou, D.
Qiu, L.
ANNALS OF ONCOLOGY, 2024, 35 : S608 - S608
[43] R-Dhaox, high dose chemotherapy (HDC) and rituximab maintenance as salvage treatment in relapsed/refractory (R/R) follicular (F) and mantle cells (MC) lymphomas (NHL)
Rupolo, M.
Michieli, M.
Spina, M.
Bulian, P.
Degan, M.
Mazzucato, M.
Abbruzzese, L.
Tirelli, U.
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
[44] Bendamustine in Combination with Gemcitabine and Vinorelbine As Salvage Regimen for Relapsed or Refractory Peripheral T-Cell Lymphomas: A Retrospective Single Center Experience
Bagnoli, Filippo
De Feo, Jacopo Calabrese
Ricci, Francesca Livia Letizia
Mariotti, Jacopo
Sarina, Barbara
Balzarotti, Monica
Taurino, Daniela
Mannina, Daniele
De Philippis, Chiara
Rahal, Daoud
Bonometti, Arturo
Magagnoli, Massimo
Mazza, Rita
Rodari, Marcello
Giordano, Laura
Bramanti, Stefania
Carlo-Stella, Carmelo
Santoro, Armando
BLOOD, 2024, 144 : 1681 - 1682
[45] Prognosing Efficacy of FLAG Regimen in the Treatment of Relapsed and Refractory AML
Budaeva, I. G.
Ovsiannikova, E. G.
Kulemina, O. V.
Motorin, D. V.
Badaev, R. S.
Zammoeva, D. B.
Ivanov, V. V.
Bogdanov, K. V.
Pisotskay, O. S.
Mirolubova, J. V.
Nikulina, T. S.
Alexeeva, Yu. A.
Zaritskey, A. Yu.
Girshova, L. L.
ANNALS OF HEMATOLOGY, 2019, 98 : S44 - S45
[46] Efficacy and Feasibility of IDEA Therapy for Refractory or Relapsed Non-Hodgkin's Lymphoma
Nishimori, Hisakazu
Fujii, Nobuharu
Maeda, Yoshinobu
Matsuoka, Ken-Ichi
Takenaka, Katsuto
Shinagawa, Katsuji
Ikeda, Kazuma
Matsuo, Keitaro
Harada, Mine
Tanimoto, Mitsune
ANTICANCER RESEARCH, 2009, 29 (05) : 1749 - 1754
[47] ASHAP -: an effective salvage therapy for recurrent and refractory malignant lymphomas
Hänel, M
Kröger, N
Hoffknecht, MM
Peters, SO
Metzner, B
Fiedler, F
Braumann, D
Schubert, JC
Illiger, HJ
Hänel, A
Krüger, WH
Zeller, W
Weh, HJ
Hossfeld, DK
Zander, AR
ANNALS OF HEMATOLOGY, 2000, 79 (06) : 304 - 311
[48] MINE-ESHAP SALVAGE THERAPY FOR RECURRENT AND REFRACTORY LYMPHOMAS
CABANILLAS, F
RODRIGUEZ, MA
SEMINARS IN HEMATOLOGY, 1994, 31 (02) : 30 - 30
[49] ASHAP – an effective salvage therapy for recurrent and refractory malignant lymphomas
M. Hänel
N. Kröger
M. M. Hoffknecht
S. O. Peters
B. Metzner
F. Fiedler
D. Braumann
J. C. Schubert
H. J. Illiger
A. Hänel
W. H. Krüger
W. Zeller
H. J. Weh
D. K. Hossfeld
A. R. Zander
Annals of Hematology, 2000, 79 : 304 - 311
[50] Rituximab Plus Gemcitabine, Ifosfamide, Oxaliplatin (R-GIFOX), a New Effective Cytoreductive/Mobilizing Salvage Regimen for Relapsed and Refractory Hodgkin Lymphoma.
Corazzelli, Gaetano
Capobianco, Gaetana
Arcamone, Manuela
Becchimanzi, Cristina
Marcacci, Giampaolo
Frigeri, Ferdinando
Russo, Filippo
Pinto, Antonio
BLOOD, 2008, 112 (11) : 901 - 902

← 1 2 3 4 5 →